StoxZydus Wellness vs CCL Products (I): share price & financials comparison
NSE: ZYDUSWELL vs CCL · Fast Moving Consumer Goods · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Zydus Wellness vs CCL Products (I) at a glance
Zydus Wellness (ZYDUSWELL) has a market capitalisation of ₹14,944 Cr, against ₹13,061 Cr for CCL Products (I) (CCL). Over the past year CCL Products (I) has returned +10.1%, compared with +1.5% for Zydus Wellness. On valuation, CCL Products (I) trades at a lower P/E of 28.3 versus 60.7. CCL Products (I) earns a higher return on equity (17.3% vs 4.2%). Zydus Wellness comes out ahead on technicals. CCL Products (I) comes out ahead on size, valuation, profitability, financial health and momentum. Across the scored metrics below, Zydus Wellness leads on 4 and CCL Products (I) on 13. On StoxGud's 10-point checklist, Zydus Wellness scores 5/10 and CCL Products (I) scores 5/10.
| Metric | Zydus Wellness | CCL Products (I) |
|---|---|---|
| Size | ||
| Market cap | ₹14,944 Cr | ₹13,061 Cr |
| Revenue (latest FY) | ₹3,961 Cr | ₹4,457 Cr |
| Net profit (latest FY) | ₹197 Cr | ₹388 Cr |
| Valuation | ||
| P/E | 60.7 | 28.3 |
| P/B | 2.53 | 4.90 |
| Dividend yield | 0.26% | 0.79% |
| Profitability | ||
| Return on equity | 4.2% | 17.3% |
| Net profit margin | 4.9% | 9.9% |
| Operating margin | 13.1% | 16.7% |
| Growth | ||
| Revenue growth (YoY) | +73.2% | +7.5% |
| Net profit growth (YoY) | — | +29.0% |
| Revenue CAGR (multi-year) | +16.2% | +29.1% |
| Financial health | ||
| Debt to equity | 0.53 | 0.45 |
| Momentum | ||
| 1-month return | -5.9% | -8.6% |
| 1-year return | +1.5% | +10.1% |
| 3-year CAGR | +15.5% | +15.6% |
| 5-year CAGR | +3.0% | +19.5% |
| 10-year CAGR | +11.3% | +15.5% |
| Distance from 52W high | -22.0% | -20.5% |
| Technicals | ||
| RSI (14) | 53 | 77 |
| Price vs 200-day avg | -4.7% | -9.3% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Zydus Wellness | CCL Products (I) |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✗ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✗ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✓ |
| Score | 5/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Zydus Wellness or CCL Products (I)?
Zydus Wellness has a market cap of ₹14,944 Cr and CCL Products (I) has a market cap of ₹13,061 Cr as of 13 Nov 2026.
Which has a lower P/E, Zydus Wellness or CCL Products (I)?
CCL Products (I) has the lower P/E: Zydus Wellness trades at 60.7 and CCL Products (I) at 28.3.
Which gave better returns in the last year, Zydus Wellness or CCL Products (I)?
CCL Products (I) did better: Zydus Wellness returned +1.5% and CCL Products (I) returned +10.1% over one year.
What is the difference between Zydus Wellness and CCL Products (I)?
Both are NSE-listed companies in Fast Moving Consumer Goods. They are about the same size by market cap (₹14,944 Cr vs ₹13,061 Cr). In the latest financial year Zydus Wellness reported revenue of ₹3,961 Cr and CCL Products (I) ₹4,457 Cr. Operating margin is 13.1% for Zydus Wellness and 16.7% for CCL Products (I). Debt to equity is 0.53 for Zydus Wellness and 0.45 for CCL Products (I).
Which is better, Zydus Wellness or CCL Products (I)?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Zydus Wellness leads on 4 and CCL Products (I) on 13. Zydus Wellness is ahead on technicals. CCL Products (I) is ahead on size, valuation, profitability, financial health and momentum. On StoxGud's rules-based checklist Zydus Wellness scores 5/10 and CCL Products (I) scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.